Restoring type VII collagen in skin

Su M. Lwin; John A. McGrath

doi:10.1016/j.medj.2022.04.008

Restoring type VII collagen in skin

Su M. Lwin, John A. McGrath

Department of Dermatology

Research output: Contribution to journal › Comment/debate › peer-review

2 Citations (Scopus)

Abstract

New therapeutic hope is emerging for people with the rare inherited blistering skin disease recessive dystrophic epidermolysis bullosa (RDEB). Gurevich et al.¹ have reported early-phase clinical trial data evaluating a topical herpes simplex virus 1 vector to restore missing type VII collagen in RDEB skin and heal wounds.

Original language	English
Pages (from-to)	273-275
Number of pages	3
Journal	Med
Volume	3
Issue number	5
DOIs	https://doi.org/10.1016/j.medj.2022.04.008
Publication status	Published - 2022 May 13

All Science Journal Classification (ASJC) codes

General Medicine

Access to Document

10.1016/j.medj.2022.04.008

Cite this

@article{e09718daaab8497ba984e6e8c5f1eab4,

title = "Restoring type VII collagen in skin",

abstract = "New therapeutic hope is emerging for people with the rare inherited blistering skin disease recessive dystrophic epidermolysis bullosa (RDEB). Gurevich et al.1 have reported early-phase clinical trial data evaluating a topical herpes simplex virus 1 vector to restore missing type VII collagen in RDEB skin and heal wounds.",

author = "Lwin, {Su M.} and McGrath, {John A.}",

note = "Publisher Copyright: {\textcopyright} 2022 Elsevier Inc.",

year = "2022",

month = may,

day = "13",

doi = "10.1016/j.medj.2022.04.008",

language = "English",

volume = "3",

pages = "273--275",

journal = "Med",

issn = "2666-6359",

publisher = "Cell Press",

number = "5",

}

TY - JOUR

T1 - Restoring type VII collagen in skin

AU - Lwin, Su M.

AU - McGrath, John A.

PY - 2022/5/13

Y1 - 2022/5/13

N2 - New therapeutic hope is emerging for people with the rare inherited blistering skin disease recessive dystrophic epidermolysis bullosa (RDEB). Gurevich et al.1 have reported early-phase clinical trial data evaluating a topical herpes simplex virus 1 vector to restore missing type VII collagen in RDEB skin and heal wounds.

AB - New therapeutic hope is emerging for people with the rare inherited blistering skin disease recessive dystrophic epidermolysis bullosa (RDEB). Gurevich et al.1 have reported early-phase clinical trial data evaluating a topical herpes simplex virus 1 vector to restore missing type VII collagen in RDEB skin and heal wounds.

UR - http://www.scopus.com/inward/record.url?scp=85129942853&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85129942853&partnerID=8YFLogxK

U2 - 10.1016/j.medj.2022.04.008

DO - 10.1016/j.medj.2022.04.008

M3 - Comment/debate

C2 - 35584643

AN - SCOPUS:85129942853

SN - 2666-6359

VL - 3

SP - 273

EP - 275

JO - Med

JF - Med

IS - 5

ER -

Restoring type VII collagen in skin

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this